Choose a Year - 2009 Grant Recipients

2009 GRANT RECIPIENTS

Marta Chesi, PhD
Mayo Clinic
Scottsdale, AZ
“In-vivo Validation of Novel Anti-Myeloma Therapies”

Madhav Dhodapkar, MD
Yale University
New Haven, CT
“Harnessing Anti-Sox2 T Cells in Myeloma Pre-Clinical Studies”

Irene Ghobrial, MD
Dana-Farber Cancer Institute
Boston, MA
“Integrin Regulation of MM Trafficking”

Siegfried Janz, PhD
University of Iowa
Iowa City, IA
“Pre-clinical Validation of IL06 for Translational Myeloma Research”

Noriyoshi Kurihara, DDS, PhD
University of Pittsburgh Medical Center
Pittsburgh, PA
“p62 Signaling as a Therapeutic Target for MM”

Suzanne Lentzsch, MD, PhD
University of Pittsburgh Medical Center
Pittsburgh, PA
“Effects of iMiDs on Granulocytic Maturation”

Yulia Nefedova, PhD
H. Lee Moffitt Cancer Center
Tampa, FL
“Targeting Wnt Signaling Network to Enhance Chemotherapy in MM”

Rao Prabhala, PhD
Boston VA Research Institute
Boston, MA
“Evaluating the in Vitro and in Vivo Effects of Targeting IL-17 in Myeloma”

Dave Roodman, MD, PhD
University of Pittsburgh Medical Center
Pittsburgh, PA
“GFI-1 Suppression of Osteoblast Differentiation in Myeloma”

Robert Williams, PhD
Colorado State University
Colorado Springs, CO
“MM Therapeutics Based on the Natural HDACi Largazole”

Shrikanta Chattopadhyah, PhD
Dana-Farber Cancer Institute
Boston, MA
“Screening for Small Molecule Inhibitors of MM within its Microenvironment”

Damian Green, MD
Fred Hutchinson Cancer Center
Seattle, WA
“Radio-immunotherapy for MM”

Haiyan Li, MD
M. D. Anderson Cancer Center
Houston, TX
“Role of Osteoclasts in the Regulation of T-Cell Immunotherapy in MM”

Vishnu Ramani, PhD
University of Alabama, Birmingham
Birmingham, AL
“Heparanese Inhibation as Anti-Metastatic Therapy for MM”

Mahadeo Sukhai, PhD
University Health Network
Toronto, Canada
“Investigating the Anti-Myeloma Effects of Cliquinol”